Legal requirements involving stability from government regulations
Helpful organizations and information
Equipment and service vendors related to the stability function
Listings, links, and summary of stability publications
A curated list of careers in stability.
Stabilitarian input on stability-related topics
Home › Forums › General Discussion › Force degradation studies for MDI Formulation in Brasil
Does anyone have information/rational/experience for conducting forced degradation studies on MDI formulations to meet Brazil RDC53 regulations?
Posted on behalf of Sylvine P. at GSK.
Some of these references may prove helpful. I’ll post your question in the discussion forum to see if other Stabilitarians might comment.
ANVISA’s Guidance on Forced Degradation Studies Explained
ANVISA’s Guidance on Forced Degradation Studies Explained – Part 2
ANVISA’s Guidance on Forced Degradation Studies Explained – Part 3
New developments in the pharmaceutical stress testing industry
Please review StabilityHub’s policies for details about data, information, and site use.
Copyright ©2022 | STABILITYHUB | ALL RIGHTS RESERVED | BUILT BY CAVETTEK, LLC